Premier Biomedical, Inc. (OTCMKTS:BIEI) Short Interest Update

Premier Biomedical, Inc. (OTCMKTS:BIEI – Get Free Report) was the target of a large decrease in short interest during the month of April. As of April 30th, there was short interest totaling 14,833 shares, a decrease of 89.8% from the April 15th total of 144,856 shares. Based on an average trading volume of 94,988,385 shares, the days-to-cover ratio is presently 0.0 days.

Premier Biomedical Stock Performance

OTCMKTS BIEI traded down $0.00 during trading on Monday, reaching $0.00. The company’s stock had a trading volume of 15,392,273 shares, compared to its average volume of 17,923,078. Premier Biomedical has a one year low of $0.00 and a one year high of $0.00.

Get Premier Biomedical alerts:

Premier Biomedical Company Profile

(Get Free Report)

Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries.

Read More

• Five stocks we like better than Premier Biomedical
• Before the Moon Base Gets Built, These 4 Companies Win
• Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
• 3 Stocks That Win If Inflation Surprises to the Downside
• MercadoLibre Boldly Invests in Growth: Discount Deepens

Receive News & Ratings for Premier Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premier Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.